Inozyme Pharma Inc (INZY)
3.42
-0.13
(-3.66%)
USD |
NASDAQ |
Nov 14, 16:00
3.50
+0.08
(+2.34%)
After-Hours: 20:00
Inozyme Pharma Total Liabilities (Quarterly): 60.57M for Sept. 30, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 60.57M |
| June 30, 2024 | 61.29M |
| March 31, 2024 | 58.11M |
| December 31, 2023 | 60.37M |
| September 30, 2023 | 45.49M |
| June 30, 2023 | 45.34M |
| March 31, 2023 | 38.45M |
| December 31, 2022 | 20.80M |
| September 30, 2022 | 19.24M |
| June 30, 2022 | 12.81M |
| Date | Value |
|---|---|
| March 31, 2022 | 14.70M |
| December 31, 2021 | 14.27M |
| September 30, 2021 | 11.77M |
| June 30, 2021 | 9.985M |
| March 31, 2021 | 10.03M |
| December 31, 2020 | 11.26M |
| September 30, 2020 | 11.08M |
| June 30, 2020 | 118.53M |
| March 31, 2020 | 4.909M |
| December 31, 2019 | 81.16M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
4.909M
Minimum
Mar 2020
118.53M
Maximum
Jun 2020
35.51M
Average
20.02M
Median
Total Liabilities (Quarterly) Benchmarks
| Tango Therapeutics Inc | 123.24M |
| CEL-SCI Corp | 15.60M |
| AIM ImmunoTech Inc | 9.613M |
| IGC Pharma Inc | 2.714M |
| NovaBay Pharmaceuticals Inc | 4.542M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 143.36M |
| Shareholders Equity (Quarterly) | 82.79M |